Відео

When the oral form of PCSK9 inhibitors become available, I hope they won't charge a fortune as they do with the injectable types. Fat chance for a reasonable price, I'm afraid.

Crap channel locked up my tv.

Which books do you recommend?

Mavacamten is the first drug for HOCM and is a game-changer.

Totally agree with Dr. Lonn on deporting all pro-Hamas thugs on McMaster campus!

Respected professor when usually you start Sglt2 inhibitors in your practice in a patient with acute mi, like immediately or 24 hours or after 72 hours or during discharge, when you want to prefer the Sglt2 inhibitor professor, thank you in anticipation.

nice

While understanding the molecular basis of desirable response is a crucial step, it is not often so easy to find a precise and reliable signal at molecular level, given sometimes individual level variations of risk exposures are often not controlled for sufficiently, partly due to the lack of existing knowledge.

Great questions and answers. Definitely a better ablation choice it seems

Well that is good news as I recently found out that I have HCM but am also going to the gym and lifting weights. I always had in the back of my head, am I doing more harm than good? I get easily winded but no chest pains so I continued. Hearing things like this puts me more at ease...which may be a bad thing if the information is incorrect.

Dr. Sareen is the best of the best!! She's an amazing cardiologist and mentor. She's compassionate and caring and really takes her profession seriously. while ensuring that she listens to each individual and helps them to met their goals and needs. 🎉❤😊 Thank you Dr. Sareen for all that you do! You definitely deserve your flowers.

Super nervous 😅 but thank you it’s insightful

Is it true that the PCSK9 inhibitors cause fatty liver? TIA.

👍

Fantastic results and clearly explained. I’m on the waiting list here in the UK for Mavacamten, as it recently received the green light from NICE. While I am tampering my expectations, all the results from the different trials are most encouraging. This is a remarkable step forward for the treatment of hypertrophic cardiomyopathy and all the scientists and clinicians involved should be congratulated.

go to hell

This woman (Eva Lonn) is extremely conservative islamophobic anti-muslim. She wanted to deport all the people in her institution who supported the Palestinian cause.

When will the oral Inhibitor be available and will side effects be as severe for some as the inj. form?

RESPECT FOR DR ANKUR KALRA

Is any treatment?

Excellent interview, thanks for inviting Dr. Kalra!

Thank you!

Promo SM ❗

Excellent

🎉

Allah Hafiz

You should go back to selling umbrellas.

More of this kind of information please.

The subject of the next POISE trial is wonderful! Thank you for this interesting interview.

It is fantastic to listen to the brief presentation of the POISE-II trial by PJ Devereaux's own voice. Thank you for uploading this valuable clip.

W

Thank you , new ways to do this important procedure, changing peoples lives in a positive way, ask me how i know....

Great innovative doctors and technologies in a search of better patient’s outcomes and experiences! Congratulations!

Waiting for Pulsed Field Ablation to be approved in the United States. In Afib as I type this.

This man Syed Naqvi has harmed multiple women.

Dr Radar is “one of the good ones”. Not all cardiologists are created equal!!

Sir,what is the treatment Ash,,+ predominant hyper trophy in mid cavity and LV apex

She's from my home state TamilNadu in India.

Should my siblings be tested. I have lipoprotein a. I'm 69, female.

I absolutely love Dr. Narula. He is a no nonsense doctor who doesn't play games. He makes cardiology so fun

Never thought

🥰

Fantastic post Anbukarasi maatan

This was such a good, thorough summary of the progress toward mavacamten approval and its likely acceptance both by the FDA and patients. Thank you so much, gentlemen.

I need this in my life

The data is unreliable and efficacy should be monitored on a case by case basis. It CAN cause ketoacidosis and hypoglycaemia in patients without diabetes. It also causes idiopathic low blood pressure levels as a result - Heart failure patient here (HFrEF 30-35 cardiomyopathy) who has trialled Dapagliflozin twice. Once in October 2021 and again in June 2022. In both instances, two different Cardiologists at two different major hospitals ceased the use of it.

🤭 𝐩𝓻Ỗ𝓂Ø𝓈Ｍ

Europe is doing faster in cardiology now

Best cardiologist of history!

How low can we safely go in cholesterol lowering..?????